Workflow
Pelthos Therapeutics (NYSEAM:PTHS) FY Conference Transcript
2026-03-23 23:02
Pelthos Therapeutics (NYSEAM:PTHS) FY Conference March 23, 2026 06:00 PM ET Company ParticipantsFrank Knuettel II - CFOScott Plesha - CEOConference Call ParticipantsJonathan Aschoff - Senior Biotechnology AnalystJonathan AschoffWelcome back. This is Jonathan Aschoff, Senior Biotechnology Analyst at Roth Capital Partners. With me now from Pelthos Therapeutics is CEO Scott Plesha and CFO Frank Knuettel II. Welcome, guys.Scott PleshaThanks, Jonathan.Jonathan AschoffWe'll start this off. Give us some background ...
The RealReal (NasdaqGS:REAL) FY Conference Transcript
2026-03-23 23:02
The RealReal (NasdaqGS:REAL) FY Conference March 23, 2026 06:00 PM ET Company ParticipantsAjay Gopal - CFONone - Company RepresentativeNoneAll right, guys. We're a little tight on time after that last transition, but we'll try to keep the trains moving on time here. Very pleased to have The RealReal here for a fireside chat. We got the CFO of The RealReal with us, Ajay Gopal. I guess we'll just jump right into the questions.Ajay GopalYeah.NoneWhat I wanted to start out with is just level setting everybody i ...
Rimini Street (NasdaqGM:RMNI) FY Conference Transcript
2026-03-23 22:02
Rimini Street (NasdaqGM:RMNI) FY Conference March 23, 2026 05:00 PM ET Company ParticipantsDavid Steinberg - CEOSeth Ravin - Chairman, President, and CEOModeratorIt never gets less. All right. I think we're good to go. Really glad to have my panelists here to talk about an issue that is near and dear to my heart today, 'cause I've been following the software industry for coming on three decades, I think now, and watching it get absolutely under attack by the fears that AI is gonna disrupt it and break all o ...
Zeta Global (NYSE:ZETA) FY Conference Transcript
2026-03-23 22:02
Zeta Global (NYSE:ZETA) FY Conference March 23, 2026 05:00 PM ET Company ParticipantsDavid Steinberg - Co-Founder, Chairman, and CEOSeth Ravin - CEO, President, and Chairman of the BoardConference Call ParticipantsRichard Baldry - Managing Director and Senior Research AnalystRichard BaldryAll right, I think we're good to go. Really glad to have my panelists here to talk about an issue that is near and dear to my heart today, 'cause I've been following the software industry for coming on three decades, I thi ...
Castle Biosciences (NasdaqGM:CSTL) Update / briefing Transcript
2026-03-23 21:32
Castle Biosciences (NasdaqGM:CSTL) Update / briefing March 23, 2026 04:30 PM ET Company ParticipantsCamilla Zuckero - VP of Investor Relations and Corporate AffairsCatherine Schulte - Director of Life Sciences Equity ResearchDerek Maetzold - President and CEOMason Carrico - Managing Director of Medical Technology Equity ResearchMatthew Goldberg - SVP of MedicalMichael Guenther - Surgical OncologistConference Call ParticipantsCarlos Penikis - Senior Equity Research AnalystThomas Flaten - Senior Equity Resear ...
Rumble (NasdaqGM:RUM) FY Conference Transcript
2026-03-23 21:02
Rumble (NasdaqGM:RUM) FY Conference March 23, 2026 04:00 PM ET Company ParticipantsChris Pavlovski - Founder and CEOConference Call ParticipantsRohit Kulkarni - Managing Director and Senior Research AnalystRohit KulkarniOkay. Thank you for joining us. My name is Rohit Kulkarni. I'm the Internet Analyst here at Roth Capital Partners. But more importantly, thanks, Chris Pavlovski, Founder and CEO of Rumble. Rumble has grown into one of the largest independent video platforms globally, built on the foundation ...
CervoMed (NasdaqCM:CRVO) FY Conference Transcript
2026-03-23 20:02
CervoMed (NasdaqCM:CRVO) FY Conference March 23, 2026 03:00 PM ET Company ParticipantsMatt Winton - CCO and CBOModeratorGood afternoon, everyone. I am Boobalan Pachaiyappan, Managing Director and Senior Biotech Analyst at Roth Capital Partners. With me today is Matt Winton, who is the Chief Commercial Officer and Chief Business Officer of CervoMed. For those who are new to the story, CervoMed is developing oral drugs for neurodegenerative diseases, including dementia with Lewy bodies, ALS, and FTD, and so o ...
Prenetics Global (NasdaqGM:PRE) FY Conference Transcript
2026-03-23 20:02
Prenetics Global (NasdaqGM:PRE) FY Conference March 23, 2026 03:00 PM ET Company ParticipantsDanny Yeung - CEO and Co-founderJason Wersland - FounderNate Raabe - Managing PartnerShadi Bakour - Co-founder and CEOShahab Elmi - Founder and CEOConference Call ParticipantsNone - AnalystNone - AnalystNate RaabeAll right, we're missing a panelist here. I think he's talking with Mr. Johnson out there, so he may join us later. We're gonna go ahead and get started here. There'll be people trickling in. My name is Nat ...
Astera Labs (NasdaqGS:ALAB) FY Conference Transcript
2026-03-23 19:32
Astera Labs (NasdaqGS:ALAB) FY Conference March 23, 2026 02:30 PM ET Company ParticipantsNick Aberle - VP of Finance, Investor Relations, and TreasurerConference Call ParticipantsSuji Desilva - Managing Director and Senior Research AnalystNone - AnalystNone - AnalystSuji DesilvaI'm a systems analyst at Roth. Usually, you know, I have to go back and look at somebody's bio when I'm meeting them, but I've known Nick most of his career. We started talking to each other when he was working at Netlogic and Broadc ...
Cronos Group (NasdaqGM:CRON) FY Conference Transcript
2026-03-23 19:32
Cronos Group (NasdaqGM:CRON) FY Conference March 23, 2026 02:30 PM ET Company ParticipantsMike Gorenstein - Chairman, President, and CEOConference Call ParticipantsNone - AnalystNoneIn a minute. Yeah, I think the clock is still. There it is. All right. I'm ready if you're ready. All right. Good morning, everybody. This is the consumer track. We're in the blue room, where we're about to hear from Cronos Group Chairman and CEO Mike Gorenstein. Mike, thank you for being here. Cronos is a leading cannabis LP, w ...